Cargando…
What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences
OBJECTIVE: The patent expiry of a number of biological medicines and the advent of biosimilars raised the expectations of healthcare commissioners that biosimilars would reduce the high cost of these medicines and produce potential savings to the NHS. We aimed to examine the prescribing pattern of d...
Autores principales: | Chapman, Stephen R, Fitzpatrick, Raymond W, Aladul, Mohammed I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541334/ https://www.ncbi.nlm.nih.gov/pubmed/28400458 http://dx.doi.org/10.1136/bmjopen-2016-013730 |
Ejemplares similares
-
Lost cost savings to the NHS in England due to the delayed entry of multiple generic low-dose transdermal buprenorphine: a case scenario analysis
por: Chapman, Stephen Robert, et al.
Publicado: (2019) -
Effects of drug price reduction and prescribing restrictions on expenditures and utilisation of antihypertensive drugs in Korea
por: Yoo, Ki-Bong, et al.
Publicado: (2015) -
Healthcare professionals’ perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study
por: Aladul, Mohammed Ibrahim, et al.
Publicado: (2018) -
Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey
por: Chapman, Stephen R, et al.
Publicado: (2017) -
What are healthcare workers’ preferences for hand hygiene interventions? A discrete choice experiment
por: Chen, Wenlin, et al.
Publicado: (2021)